tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jay Olson, 333 are a BUY (92.24%), 27 are a HOLD (7.48%), 1 are a SELL (0.28%).
Analyst Jay Olson, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 45.68% that have a potential upside of 32.94% achieved within 173 days.
Jay Olson’s has documented 780 price targets and ratings displayed on 52 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.
Most recent stock forecast was given on MDGL, Madrigal Pharmaceuticals at 09-Oct-2025.
Analyst best performing recommendations are on CINC (CINCOR PHARMA).
The best stock recommendation documented was for PRTA (PROTHENA PLC) at 6/1/2021. The price target of $45 was fulfilled within 10 days with a profit of $17.56 (63.99%) receiving and performance score of 63.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$33
$10.98 (49.86%)
$34
1 months 1 days ago
(28-Sep-2025)
8/13 (61.54%)
$11.68 (54.78%)
113
Buy
$28
$5.98 (27.16%)
$30
1 months 6 days ago
(23-Sep-2025)
0/10 (0%)
$6.74 (31.70%)
Buy
$39
$16.98 (77.11%)
$35
1 months 19 days ago
(10-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
Buy
$39
$16.98 (77.11%)
$32
1 months 21 days ago
(08-Sep-2025)
1/5 (20%)
$14.16 (57.00%)
349
Hold
$24
$1.98 (8.99%)
$23
2 months 23 days ago
(06-Aug-2025)
10/13 (76.92%)
$-0.4 (-1.64%)
157
Which stock is Jay Olson is most bullish on?
Which stock is Jay Olson is most reserved on?
What Year was the first public recommendation made by Jay Olson?
